NEOGENOMICS INC — Director's Dealing 2022

Dec 8, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NEOGENOMICS INC (NEO)
CIK: 0001077183
Period of Report: 2022-12-05

Reporting Person: Sherman Jeffrey Scott (Chief Financial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-12-05	Common Stock	A	44603	—	Acquired	44603	Direct
2022-12-05	Common Stock	A	89206	—	Acquired	133809	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-12-05	Stock Option (Right to Buy)	$11.62	A	249169	Acquired	2029-12-05	Common Stock (249169.0)	Direct

Footnotes

F1: On December 5, 2022, Mr. Sherman was granted an award of 44,603 shares of restricted stock. The shares subject to this award shall vest ratably over four years with the first tranche vesting on December 7, 2023.

F2: On December 5, 2022, Mr. Sherman was granted an award of 89,206 shares of restricted stock. The shares subject to this award shall vest upon the achievement of an absolute total stockholder return of at least 20% for the period commencing December 7, 2022 and ending December 6, 2023. If such vesting condition is met, the shares subject to the award shall vest ratably over four years with the first tranche vesting on December 7, 2023.

F3: On December 5, 2022, Mr. Sherman was granted 249,169 stock options. These awards vest ratably over four years with the first tranche vesting on December 7, 2023.